Raphael Pollock, MD, PhD, has a very personal connection to Pelotonia-funded research. The annual fundraising bike ride provided the initial funding for Acalabrutinib, "the drug that’s keeping me alive," says the director of The Ohio State University Comprehensive Cancer Center. In this episode, Pollock – who was diagnosed with chronic lymphocytic leukemia - provides an overview of several of the major areas of research, recruitment and screening funded by what he calls “the sweat equity” of the thousands of Pelotonia riders, volunteers and donors. Pelotonia has raised more than $220 million, and every dollar funds research at the OSUCCC – James. It has funded scores of idea grants, more than 500 Pelotonia Fellowships, the recruitment of top docs from around the world, the Pelotonia Institute of Immuno-Oncology, and four statewide screening programs that have already saved a lot of lives. “Pelotonia has been remarkable in terms of its scope and magnitude and the means in which it brings together so many dedicated participants from the community and connects them to the research efforts at our cancer center,” Pollock said.